Leonard Braden Michael's Form 4 filing
AN2 Therapeutics, Inc. (ANTX) · filed May 30, 2025
- Accession no.
- 0001373604-25-000084
- Filed
- May 30, 2025
- Trade date
- May 28-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.87M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Braden MichaelCIK 0001373603 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | Common Stock | SSaleDisposed | −2,000,000 | $1.16 | −$2,320,000 | 3,749,432 | Indirect | |
| May 28, 2025 | Common Stock | SSaleDisposed | −100,000 | $1.16 | −$116,000 | 3,649,432 | Indirect | |
| May 30, 2025 | Common Stock | SSaleDisposed | −425,000 | $1.01 | −$429,250 | 3,224,432 | Indirect | |
| May 30, 2025 | Common Stock | SSaleDisposed | −7,000 | $1.03 | −$7,210 | 3,217,432 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.